sr 48692 has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, H; Dai, Y; Feng, H; Gong, X; Ouyang, Q; Xiao, H; Xu, L; Xu, M; Yi, L; Zhou, J | 1 |
| Akter, H; Kang, MJ; Kwon, OS; Park, M; Park, WS; Song, EJ | 1 |
2 other study(ies) available for sr 48692 and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Neoplasm Invasiveness; Neurotensin; Phosphorylation; Prognosis; Protein Precursors; Pyrazoles; Quinolines; Receptors, Neurotensin | 2015 |
Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; Neurotensin; Phosphatidylinositol 3-Kinases; Pyrazoles; Quinolines; Stomach Neoplasms; Transcriptional Activation | 2015 |